308 related articles for article (PubMed ID: 9086008)
21. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
[TBL] [Abstract][Full Text] [Related]
22. Interaction of cyclosporin derivatives with the ATPase activity of human P-glycoprotein.
Watanabe T; Kokubu N; Charnick SB; Naito M; Tsuruo T; Cohen D
Br J Pharmacol; 1997 Sep; 122(2):241-8. PubMed ID: 9313931
[TBL] [Abstract][Full Text] [Related]
23. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines.
van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH
Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167
[TBL] [Abstract][Full Text] [Related]
24. Potentiation of the reversal activity of SDZ PSC833 on multi-drug resistance by an anti-P-glycoprotein monoclonal antibody MRK-16.
Naito M; Watanabe T; Tsuge H; Koyama T; Oh-hara T; Tsuruo T
Int J Cancer; 1996 Jul; 67(3):435-40. PubMed ID: 8707421
[TBL] [Abstract][Full Text] [Related]
25. Correlation of expression levels of P-glycoprotein with resistance to adriamycin in a renal adenocarcinoma cell line.
Kawamoto S; Deguchi T; Nezesa S; Yamada S; Okano M; Kawada Y
Urol Res; 1997; 25(6):407-12. PubMed ID: 9443650
[TBL] [Abstract][Full Text] [Related]
26. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
Jiang XR; Kelsey SM; Wu YL; Newland AC
Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
[TBL] [Abstract][Full Text] [Related]
27. SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia.
Keller RP; Altermatt HJ; Nooter K; Poschmann G; Laissue JA; Bollinger P; Hiestand PC
Int J Cancer; 1992 Feb; 50(4):593-7. PubMed ID: 1347037
[TBL] [Abstract][Full Text] [Related]
28. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin ototoxicity is induced in mice by combination treatment with cyclosporin A.
Saito T; Zhang ZJ; Tokuriki M; Shibamori Y; Yamamoto T; Noda I; Ohtsubo T; Saito H
Acta Otolaryngol; 2001 Oct; 121(7):787-93. PubMed ID: 11718240
[TBL] [Abstract][Full Text] [Related]
30. Use of a peptide mimotope to guide the humanization of MRK-16, an anti-P-glycoprotein monoclonal antibody.
Tang Y; Beuerlein G; Pecht G; Chilton T; Huse WD; Watkins JD
J Biol Chem; 1999 Sep; 274(39):27371-8. PubMed ID: 10488067
[TBL] [Abstract][Full Text] [Related]
31. A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
Nokihara H; Yano S; Nishioka Y; Hanibuchi M; Higasida T; Tsuruo T; Sone S
Jpn J Cancer Res; 2001 Jul; 92(7):785-92. PubMed ID: 11473730
[TBL] [Abstract][Full Text] [Related]
32. Suppression of NF-κB signaling and P-glycoprotein function by gambogic acid synergistically potentiates adriamycin -induced apoptosis in lung cancer.
Wang LH; Yang JY; Yang SN; Li Y; Ping GF; Hou Y; Cui W; Wang ZZ; Xiao W; Wu CF
Curr Cancer Drug Targets; 2014; 14(1):91-103. PubMed ID: 24245692
[TBL] [Abstract][Full Text] [Related]
33. Expression behavior of 85-kDa membrane protein in adriamycin-resistant tumor cells and the inhibition of human tumor growth in athymic mice by MRK-20 monoclonal antibody against the protein.
Ishii S; Naito M; Tsuruo T
Jpn J Cancer Res; 1993 Jul; 84(7):776-82. PubMed ID: 8370652
[TBL] [Abstract][Full Text] [Related]
34. Possibility of the reversal of multidrug resistance and the avoidance of side effects by liposomes modified with MRK-16, a monoclonal antibody to P-glycoprotein.
Matsuo H; Wakasugi M; Takanaga H; Ohtani H; Naito M; Tsuruo T; Sawada Y
J Control Release; 2001 Nov; 77(1-2):77-86. PubMed ID: 11689261
[TBL] [Abstract][Full Text] [Related]
35. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.
Coley HM; Twentyman PR; Workman P
Biochem Pharmacol; 1989 Dec; 38(24):4467-75. PubMed ID: 2604747
[TBL] [Abstract][Full Text] [Related]
36. Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance.
Vredenburg MR; Ojima I; Veith J; Pera P; Kee K; Cabral F; Sharma A; Kanter P; Greco WR; Bernacki RJ
J Natl Cancer Inst; 2001 Aug; 93(16):1234-45. PubMed ID: 11504769
[TBL] [Abstract][Full Text] [Related]
37. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
38. Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
Chiodini B; Bassan R; Barbui T
Leuk Lymphoma; 1999 May; 33(5-6):485-97. PubMed ID: 10342576
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.
Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
J Med Chem; 2002 Oct; 45(21):4598-612. PubMed ID: 12361387
[TBL] [Abstract][Full Text] [Related]
40. P-glycoprotein-mediated multidrug resistance is modulated by pretreatment with chemosensitizers in HCT-8 carcinoma cells in vitro.
Haberl I; Swatonek H; Schaufler K; Ulsperger E; Wenzl E; Theyer G; Hamilton G; Thalhammer T
Int J Oncol; 1998 May; 12(5):1137-42. PubMed ID: 9538140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
